FDA Investigator: Christine M. Smith

- Christine M. Smith first started conducting FDA inspections in 2000, with the last inspection in 2022. Over that time, Christine M. Smith has conducted 21 inspections at 21 companies across 21 sites.

Get Christine Smith's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 Biovail Contract Research, Toronto | 2003

Out-of-stock
Christine M. Smith
Human Drug Form 483

FDA 483 Ore Pharmaceuticals Inc, Gaithersburg | 2001

Out-of-stock
Christine M. Smith
Human Drug Form 483

FDA 483 Bioreliance Corporation, Rockville | 2001

Out-of-stock
Christine M. Smith
Human Drug Form 483

FDA 483 Tornatore, Carlo S. MD, Washington | 2001

Out-of-stock
Christine M. Smith
Biologic Form 483

FDA 483 Fidia Pharmaceutical Corp, Washington | 2001

Out-of-stock
Christine M. Smith
Human Drug Form 483

FDA 483 Covance Laboratories, Inc., Vienna | 2001

Out-of-stock
Christine M. Smith
Human Drug Form 483

FDA 483 NIH Combined Neuroscience IRB-Blue, Bethesda | 2000

Out-of-stock
Christine M. Smith
Biologic Form 483

FDA 483 Schiffmann, Raphael MD, Dallas | 2000

Out-of-stock
Christine M. Smith
Biologic Form 483

FDA 483 American Histolabs Inc, Gaithersburg | 2000

Out-of-stock
Christine M. Smith
Human Drug Form 483

FDA 483 Dunbar, Cynthia E., M.D., Bethesda | 2000

Out-of-stock
Christine M. Smith
Biologic Form 483

FDA 483 Stark, James J., Portsmouth | 2000

Out-of-stock
Christine M. Smith
Human Drug Form 483

FDA 483 Shabazz, Lloyd A, Portsmouth | 2000

Out-of-stock
Christine M. Smith
Biologic Form 483

FDA 483 Candotti, Fabio MD, Bethesda | 2000

Out-of-stock
Christine M. Smith
Biologic Form 483

FDA 483 Rusinowitz, Martin S., M.D., Rockville | 2000

Out-of-stock
Christine M. Smith
Human Drug Form 483